Literature DB >> 2237261

HPLC separation and quantification of bilirubin and its glucuronide conjugates in faeces and intestinal contents of germ-free rats.

H Saxerholt1, V Skar, T Midtvedt.   

Abstract

We describe an accurate reverse-phase high-performance liquid chromatography (HPLC) method for the separation and quantification of unconjugated bilirubin (UCB) and its monoglucuronide (BMG) and diglucuronide (BDG) conjugates in faeces and intestinal contents from germ-free (GF) rats. We demonstrated that female GF rats excreted predominantly BMG and that the percentage of this conjugate was at most 71.7% of the total bilirubin excreted with the faeces. The highest percentages for BDG and the UCB were 27.9% and 6.0%, respectively. The bile pigment composition in duodenal contents was 59.8% BDG and 40.2% BMG (median percentage) and was 47.7% BDG, 50.1% BMG and 2.2% UCB in ileal contents. Deconjugation of BDG to BMG was profound in caecal contents with 26.0% BDG, 67.4% BMG and 6.6% UCB. Endogenous (mammalian) beta-glucuronidase activity was present in intestinal contents throughout the entire length of the intestine and in faeces of the GF rats. The results indicated that it is very likely that endogenous beta-glucuronidase plays a role in the deconjugation of bilirubin glucuronides as well as of other glucuronides in the intestine of the GF rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2237261     DOI: 10.1080/00365519009089163

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  Establishment of Lactobacillus and Bifidobacterium species in germfree mice and their influence on some microflora-associated characteristics.

Authors:  K E Norin; A K Persson; H Saxerholt; T Midtvedt
Journal:  Appl Environ Microbiol       Date:  1991-06       Impact factor: 4.792

2.  A product of heme catabolism modulates bacterial function and survival.

Authors:  Christopher L Nobles; Sabrina I Green; Anthony W Maresso
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.